A team of scientists said Wednesday they had developed a male oral contraceptive that was 99 percent effective in mice and didn't cause observable side effects, with the drug expected to enter human trials by the end of this year.
A is converted into different forms, including retinoic acid, which plays important roles in cell growth, sperm formation, and embryo development.
"If we know what the keyhole looks like, then we can make a better key – that's where the computational model comes in," said Noman. "I'm optimistic this will move forward quickly," she said, envisaging a possible timeline to market in five years or under.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: